BioCentury
ARTICLE | Distillery Techniques

Drug platforms

May 23, 2017 8:33 PM UTC

Crystallographic analyses of a PAR2 variant bound to PAR2 inhibitors could guide the design of therapies for cancer, inflammation and other PAR2-dependent diseases. The PAR2 variant contained point mu...